Speakers & Presenters

Seattle, Washington, United States

Gil Beyen

CEO, ERYTECH PHARMA

ERYTECH Pharma

Lyon, France

Abhijit Bhatia, MBA, MS

VICE PRESIDENT OF GLOBAL CORPORATE & BUSINESS DEVELOPMENT, RAKUTEN MEDICAL JAPAN K.K.

Rakuten Medical, Inc.

San Diego, California, United States

Greg Bosch, MBA

CHIEF EXECUTIVE OFFICER, GEISTLICH PHARMA NORTH AMERICA, INC

Geistlich Pharma

Princeton, New Jersey, United States

Christopher Bradley, MSC

CEO, LOKI THERAPEUTICS

Loki Therapeutics

Long Island City, New York, United States

Aoife Brennan, BAO, BCH, MRCPI

CEO AND PRESIDENT, SYNLOGIC

Synlogic

Cambridge, Massachusetts, United States

Paul Brennan, MSC, BSC

PRESIDENT & CEO, NERVGEN PHARMA

NervGen Pharma Corp.

Vancouver, British Columbia, Canada

Ari Brettman

MANAGING DIRECTOR, BLACKSTONE LIFE SCIENCES

Manhattan, New York, United States

Isaac Bright, MD

CEO, RUBRYC THERAPEUTICS, INC.

RubrYc Therapeutics, Inc.

San Carlos, California, United States

Robert Brooks, JD

CEO, ALPHAGENERON PHARMACEUTICALS, INC.

Alphageneron Pharmaceuticals

Cambridge, Massachusetts, United States

Carlos Buesa, PHD

CHIEF EXECUTIVE OFFICER, ORYZON GENOMICS, S.A.

Oryzon Genomics SA

Barcelona, Spain

Benjamin Carpenter

GLOBAL HEAD OF LIFE SCIENCES M&A, CITI

Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow

San Francisco, California, United States

James Caruso

PRESIDENT, CEO & DIRECTOR, CELLECTAR BIOSCIENCES, INC.

Cellectar Biosciences

Florham Park, New Jersey, United States

Alan Cash, MSC

CEO, METVITAL, INC.

MetVital, Inc.

San Diego, California, United States

Sharon Chan

HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON

Shanghai, China

Daniel Chancellor

THOUGHT LEADERSHIP DIRECTOR, INFORMA

New York, New York, United States

Shomesh Chaudhuri

CTO, QLS ADVISORS

George Chen, MBA, MD

CHAIRMAN AND CEO, D3 BIO

SHanghai, China

Lillian Chiang, PHD, MBA

CEO, EVRYS BIO

Evrys Bio

Doylestown, Pennsylvania, United States

Dohyun Cho, PHD

DR., ENZYCHEM LIFESCIENCES

Enzychem Lifesciences

Englewood Cliffs, New Jersey, United States

Judy Chou, PHD

CEO AND PRESIDENT, ALTRUBIO, INC.

AltruBio, Inc.

Redwood City, California, United States

Will Chou

CEO, ARUVANT SCIENCES, INC.

Aruvant Sciences, Inc.

New York, New York, United States

Erick Co, PHD

CHIEF EXECUTIVE OFFICER, FORMOSA PHARMACEUTICALS

Formosa Pharmaceuticals, Inc.

Taipei, Taiwan

Max Cynader

CEO, PRIMARY PEPTIDES INC

Primary Peptides Inc

Vancouver, British Columbia, Canada

Joseph Damond

EXECUTIVE VICE PRESIDENT, INTERNATIONAL AFFAIRS, BIO

Ulrich Dauer, PHD

CEO, VIVORYON THERAPEUTICS N.V.

Vivoryon Therapeutics

Halle (Saale), Germany

Marianne De Backer, PhD

MEMBER OF THE EXECUTIVE COMMITTEE, EXECUTIVE VICE PRESIDENT AND HEAD OF STRATEGY, BUSINESS DEVELOPMENT AND LICENSING, BAYER PHARMACEUTICALS, BAYER AG

Market Outlook: Breaking More Records or Expecting a Releveling?

Berlin, Germany

Allison DeAngelis

SENIOR HEALTHCARE REPORTER, BUSINESS INSIDER

Market Outlook: Breaking More Records or Expecting a Releveling?

New York, New York, United States

Jim DeMesa

PRESIDENT & CHIEF EXECUTIVE OFFICER, EMERALD HEALTH PHARMACEUTICALS

Emerald Health Pharmaceuticals

San Diego, California, United States

Anh Do

PARTNER, INDUS CAPITAL PARTNERS

Market Outlook: Breaking More Records or Expecting a Releveling?

New York, New York, United States

David Dodd

CHAIRMAN, CEO, GEOVAX LABS, INC

GeoVax Labs, Inc.

Atlanta, Georgia, United States

Douglas Doerfler

PRESIDENT & CEO, MAXCYTE, INC.

MaxCyte, Inc.

Gaithersburg, Maryland, United States

Rai Downs

PARTNER, TARPLIN, DOWNS & YOUNG LLC

Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in Congress and the White House

Washington, District of Columbia, United States

Denis Dufrane, PHD, MD

CEO & FOUNDER, NOVADIP BIOSCIENCES SA

Novadip Biosciences sa

Mont-Saint-Guibert, Belgium

Greg Duncan, MBA

CHAIRMAN AND CEO, VIRIOS THERAPEUTICS

Virios Therapeutics

Alpharetta, Georgia, United States

Mark Emalfarb

CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC

Dyadic International, Inc.

Jupiter, Florida, United States

Steven Engle

CHIEF EXECUTIVE OFFICER, COHBAR INC.

CohBar, Inc.

Menlo Park, California, United States

Eric Falcand Sr.

VP HEAD OF BUSINESS DEVELOPMENT & LICENSING, SERVIER

Servier

Suresnes cedex, France

Robert Fallon

PRESIDENT & CEO, PHOSPLATIN THERAPEUTICS

Phosplatin Therapeutics

New York, New York, United States

Bernard Fallon

MANAGING DIRECTOR, INDUSTRY RESEARCH, INVESTOR OUTREACH, AND EDUCATION, BIOTECHNOLOGY INNOVATION ORGANIZATION

Robert Foster

CEO, HEPION PHARMACEUTICALS, INC.

Hepion Pharmaceuticals, Inc.

Edison, New Jersey, United States

John Fowler

CHIEF EXECUTIVE OFFICER, KEZAR LIFE SCIENCES

Kezar Life Sciences, Inc.

South San Francisco, California, United States

Marisa Frackman

MANAGING DIRECTOR, CAPITAL MARKETS ADVISORY, WESTWICKE, AN ICR COMPANY

Baltimore, Maryland, United States

Greg Friberg

VP, GLOBAL DEVELOPMENT, AMGEN INC.

Thousand Oaks, California, United States

Adena T. Friedman

PRESIDENT AND CHIEF EXECUTIVE OFFICER, NASDAQ, INC.

Biotech's Finest Hour: A Discussion on Corporate Leadership and Equity

Steven Fruchtman, MD

PRESIDENT & CEO, ONCONOVA THERAPEUTICS, INC.

Onconova Therapeutics, Inc.

Newtown, Pennsylvania, United States

Jeffrey Galvin

CHIEF EXECUTIVE OFFICER, AMERICAN GENE TECHNOLOGIES INTERNATIONAL INC.

American Gene Technologies

Rockville, Maryland, United States

Craig Garthwaite

PROFESSOR, KELLOGG SCHOOL OF MANAGEMENT

Chicago, Illinois, United States

Bobby Gaspar, PHD, MD

CHIEF EXECUTIVE OFFICER, ORCHARD THERAPEUTICS NA

Orchard Therapeutics

Boston, Massachusetts, United States

Julie Gerberding, MD, MPH

EXECUTIVE VICE PRESIDENT AND CHIEF PATIENT OFFICER, STRATEGIC COMMUNICATIONS, GLOBAL PUBLIC POLICY, MERCK

Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in Congress and the White House

Gwynedd, Pennsylvania, United States

Geno Germano

PRESIDENT & CHIEF EXECUTIVE OFFICER, ELUCIDA ONCOLOGY, INC

Elucida Oncology

Monmouth Junction, New Jersey, United States

Albert Gianchetti, MBA

PRESIDENT & CEO, XYLOCOR THERAPEUTICS

XyloCor Therapeutics

Malvern, Pennsylvania, United States

David Giljohann, PHD

CEO, EXICURE, INC.

Exicure

Chicago, Illinois, United States

Michelle Gilson

ANALYST, CANACCORD GENUITY

New York, New York, United States

Guy Goldberg

CHIEF BUSINESS OFFICER, REDHILL BIOPHARMA LTD.

RedHill Biopharma

Tel Aviv, Israel

Asthika Goonewardene

MANAGING DIRECTOR, EQUITY RESEARCH, BIOTECH, TRUIST SECURITIES

Jonas Grossman

PRESIDENT, CHARDAN

New York, New York, United States

Jessica Grossman, MD

CEO, IGGENIX, INC.

IgGenix

South San Francisco, California, United States

Mary Haak-Frendscho, PHD

PRESIDENT AND CEO, SPOTLIGHT THERAPEUTICS INC.

CRISPR’s Progress for Patients: Clinical Development of Therapies

Hayward, California, United States

Ahmed Hamdy

VINCERX, CEO AND CHAIRMAN OF THE BOARD OF DIRECTORS

Michael Handley

CEO, CYTOCOM, INC.

Cytocom, Inc.

Fort Collins, Colorado, United States

Dror Harats, MD

CHIEF EXECUTIVE OFFICER, VASCULAR BIOGENICS LTD.

VBL Therapeutics

Modi'in, Israel

Michael Hay

GENERAL MANAGER - AMERICAS, INFORMA

New York, New York, United States

Michael Hayden, PhD

CEO, PRILENIA

Prilenia

Herzliya, Israel

Brian Heaphy, JD

VICE PRESIDENT, CORPORATE DEVELOPMMENT, BRISTOL MYERS SQUIBB COMPANY

Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow

Princeton, New Jersey, United States

Bill Hearl

PRESIDENT & CEO, IMMUNOMIC THERAPEUTICS, INC

Immunomic Therapeutics, Inc.

Rockville, Maryland, United States

Marc Hedrick, MD

PRESIDENT/CEO, PLUS THERAPEUTICS

Plus Therapeutics

Austin, Texas, United States

Laurie Heilmann

CEO, NOTABLE LABS

Notable Labs

Foster City, California, United States

Per Hellsund, MBA

PRESIDENT & CEO, CYBREXA THERAPEUTICS

Cybrexa

New Haven, Connecticut, United States

Joseph Hernandez

CHIEF EXECUTIVE OFFICER, BLUE WATER VACCINES

Sharon Hesterlee, PHD

CHIEF RESEARCH OFFICER, MUSCULAR DYSTROPHY ASSOCIATION (MDA)

Muscular Dystrophy Association

Chicago, Illinois, United States

Zachary Hornby

CEO, BOUNDLESS BIO INC.

La Jolla, California, United States

Patricia Hurter

CEO, LYNDRA THERAPEUTICS

Lyndra Therapeutics

Watertown, Massachusetts, United States

Darren Ji, PHD, MD, MBA

CEO, ELPISCIENCE BIOPHARMA

Elpiscience Biopharma

Shanghai, Shanghai, China

Pierre-Louis Joffrin

CORPORATE DEVELOPMENT OFFICER, MOGRIFY LIMITED

Mogrify Limited

Cambridge, United Kingdom

Anthony Johnson

PRESIDENT/CEO, KODIKAZ THERAPEUTIC SOLUTIONS, INC

Kodikaz Therapeutic Solutions, Inc.

New York, New York, United States

Troels Jordansen

CHAIRMAN/CEO, GLYCOSTEM THERAPEUTICS

Glycostem Therapeutics B.V.

Oss, Netherlands

Avnish Kapoor, PHD

DIRECTOR, EMERGING TECHNOLOGY & INNOVATION - CAMBRIDGE, ELI LILLY AND COMPANY

Cambridge, Massachusetts, United States

Anna Kazanchyan, MD

CHIEF EXECUTIVE OFFICER, SAGHMOS THERAPEUTICS

Saghmos Therapeutics, Inc.

Greenwich, Connecticut, United States

Colin Kealey

VICE PRESIDENT OF MEDICAL AFFAIRS, NEUROSIGMA, INC.

NeuroSigma, Inc.

Los Angeles, California, United States

Hans Keirstead

CHAIRMAN & CEO, AIVITA BIOMEDICAL, INC.

AIVITA Biomedical, Inc.

Irvine, California, United States

Sunyoung Kim, DPHIL

CEO, HELIXMITH CO., LTD

Helixmith Co., Ltd

San Diego, California, United States

Christopher Kirk

PRESIDENT & CSO, KEZAR LIFE SCIENCES

South San Francisco, California, United States

Michael Kokesh

PRESIDENT & CEO, VICARDIA THERAPEUTICS, INC.

ViCardia Therapeutics Inc.

San Francisco, California, United States

Peter Kolchinsky, PhD

MANAGING PARTNER, RA CAPITAL MANAGEMENT, LLC

Boston, Massachusetts, United States

Adam Koppel, MD, PHD

MANAGING DIRECTOR, BAIN CAPITAL, LP

Fireside Chat: Adam Koppel, MD, PhD, Managing Director, Life Sciences, Bain Capital, LP

Boston, Massachusetts, United States

Ella Korets-Smith, MBA, MSC

CHIEF BUSINESS OFFICER, VIRICA BIOTECH

Virica Biotech

Ottawa, Ontario, Canada

Sara Lafever

DIRECTOR OF CONTENT, BIOMEDTRACKER, INFORMA

San Diego, California, United States

Karim Lalji

CHIEF EXECUTIVE OFFICER, MICROBION CORPORATION

Microbion Corporation

Seattle, Washington, United States

Pat Lawman, PHD

CEO, MORPHOGENESIS INC.

Morphogenesis, Inc.

Tampa, Florida, United States

Seth Lederman, MD

CHIEF EXECUTIVE OFFICER, TONIX PHARMACEUTICALS, INC

Tonix Pharmaceuticals

New York, New York, United States

Arlinda Lee, PHD

MANAGING DIRECTOR, CANACCORD GENUITY

New York, New York, United States

Luke Lee

CEO, SHAPERON INC.

Shaperon Inc.

Seoul, Korea, Republic of

Shawn Leland, PHARMD, RPH

FOUNDER & CBO, ELEVATION ONCOLOGY

Elevation Oncology

New York, New York, United States

Rami Levin

PRESIDENT AND CHIEF EXECUTIVE OFFICER, SANIONA

Saniona AB

Waltham, Massachusetts, United States

Matt Liddelow, PHARMD, BSC

CEO & MANAGING DIRECTOR, NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD

NeuroScientific Biopharmaceuticals Ltd

Cottesloe, Western Australia, Australia

Robert Linke, MBA

CEO, OSMOL THERAPEUTICS, INC.

Osmol Therapeutics, Inc.

New Haven, Connecticut, United States

Casey Lippmeier

VP, RESEARCH AND DEVELOPMENT, CONAGEN, INC

Conagen

Bedford, Massachusetts, United States

Yue Liu, PHD

PRESIDENT, AB STUDIO INC

Ab Studio, Inc.

Hayward, California, United States

Andrew Lo

CO-FOUNDER, QLS ADVISORS

David Lockhart, PHD

CEO, RECODE THERAPEUTICS, INC.

Menlo Park, California, United States

Andrew Luber

PRESIDENT & CHIEF EXECUTIVE OFFICER, VIRION THERAPEUTICS

Virion Therapeutics

Voorhees, New Jersey, United States

Albert Luderer

CEO, INDI MOLECULAR, INC.

Indi Molecular

West Newbury, Massachusetts, United States

Maria Maccecchini, PHD

PRESIDENT & CEO, ANNOVIS BIO, INC.

Annovis Bio, Inc.

Berwyn, Pennsylvania, United States

Ibs Mahmood

CEO, AMO PHARMA

AMO Pharma

Durham, North Carolina, United States

Brad Margus

CEO, CEREVANCE

Cerevance

Boston, Massachusetts, United States

Tyler Martin, MD

CEO, ADJUVANCE TECHNOLOGIES, INC.

Adjuvance Technologies

Lincoln, Nebraska, United States

Sabrina Martucci Johnson

PRESIDENT & CEO, DARé BIOSCIENCE

Daré Bioscience

San Diego, California, United States

Lauren Martz

SENIOR EDITOR, BIOCENTURY INC.

CRISPR’s Progress for Patients: Clinical Development of Therapies

Redwood City, California, United States

Melanie Matheu

CEO, PRELLIS BIOLOGICS

Prellis Biologics

Hayward, California, United States

Glenn Mattes

PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR, TFF PHARMACEUTICALS

TFF Pharmaceuticals, Inc.

Charlestown, Massachusetts, United States

David Mazzo, PHD

PRESIDENT & CEO, CALADRIUS BIOSCIENCES, INC

Caladrius Biosciences, Inc.

Basking Ridge, New Jersey, United States

Michelle McMurry-Heath, MD, PhD

PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION

Biotech's Finest Hour: A Discussion on Corporate Leadership and Equity

Washington, United States

Tony Meehan, MBA, PhD

CHIEF BUSINESS OFFICER, VENATORX PHARMACEUTICALS, INC.

Venatorx Pharmaceuticals, Inc.

Malvern, Pennsylvania, United States

Michael E. Meyers, MPH

VICE CHAIRMAN, HEAD OF M&A AND STRATEGIC ADVISORY SERVICES, H.C. WAINWRIGHT & COMPANY

Fireside Chat: Rahul Singhvi, SC.D., M.B.A, Chief Executive Officer and Director, National Resilience, Inc.

New York, New York, United States

Sky Milch

PARTNER, PRICEWATERHOUSECOOPERS, LLP

Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow

New York, New York, United States

James Moe

PRESIDENT, OLIGOMERIX, INC.

Oligomerix.com

Bronx, New York, United States

TIMOTHY MORRIS

COO/CFO, HUMANIGEN, INC.

Humanigen, Inc

Burlingame, California, United States

John A. Murphy III

VICE PRESIDENT AND DEPUTY GENERAL COUNSEL, BIOTECHNOLOGY INNOVATION ORGANIZATION

Washington, United States

Shankar Musunuri, PHD, MBA

CHIEF EXECUTIVE OFFICER, OCUGEN

Ocugen, Inc.

Malvern, Pennsylvania, United States

Sahm Nasseri

CEO, PYC THERAPEUTICS

New York, New York, United States

Carolyn Ng

MANAGING DIRECTOR, VERTEX VENTURES

Daniel O'Connor, JD

PRSIDENT & CEO, ONCOSEC IMMUNOTHERAPIES

OncoSec Medical Incorporated

Pennington, New Jersey, United States

Kay Olmstead

CEO, NANO PHARMASOLUTIONS, INC.

Nano PharmaSolutions, Inc.

San Diego, California, United States

John Oyler

CO-FOUNDER, CEO AND CHAIRMAN OF THE BOARD, BEIGENE

Carlo Passeri

DIRECTOR, CAPITAL MARKETS & FINANCIAL SERVICES POLICY, BIOTECHNOLOGY INNOVATION ORGANIZATION

Washington, District of Columbia, United States

Snehal Patel

CHIEF EXECUTIVE OFFICER, GREENWICH LIFESCIENCES

Greenwich LifeSciences

Sugar Land, Texas, United States

Joseph Payne, MSC

FOUNDER, PRESIDENT & CEO, ARCTURUS THERAPEUTICS

Arcturus Therapeutics

San Diego, California, United States

Adelene Perkins, MBA

CHAIR & CHIEF EXECUTIVE OFFICER, INFINITY PHARMACEUTICALS, INC.

Infinity Pharmaceuticals

Cambridge, Massachusetts, United States

Guillaume Pfefer

CEO, SENDA BIOSCIENCES

Senda Biosciences

Cambridge, Massachusetts, United States

Richard Pops

CHAIRMAN & CEO, ALKERMES, INC.

Policy Outlook: Reviewing the Pathway for Advancing Biopharma Goals in Congress and the White House

Waltham, Massachusetts, United States

Steven Potts, PHD, MBA

COFOUNDER, CEO AND DIRECTOR, ONCOMYX THERAPEUTICS

OncoMyx Therapeutics, Inc.

Phoenix, Arizona, United States

Krishna Prasad

FOUNDER, CITRANVI BIOSCIENCES LLC

CITRANVI BIOSCIENCES

Chapel Hill, North Carolina, United States

Dennis Purcell, MBA

FOUNDER, AISLING CAPITAL LLC

Market Outlook: Breaking More Records or Expecting a Releveling?

New York, New York, United States

John Ramunas

CEO, REJUVENATION TECHNOLOGIES INC.

Rejuvenation Technologies Inc.

Deborah Rathjen, PHD

EXECUTIVE CHAIR, BIOASIS TECHNOLOGIES, INC.

Bioasis Technologies Inc.

Guilford, Connecticut, United States

Neal J. Reenan

PARTNER, LATHAM & WATKINS, LLP

Fireside Chat: Adam Koppel, MD, PhD, Managing Director, Life Sciences, Bain Capital, LP

Boston, Massachusetts, United States

Tom Reeves

PRESIDENT & CEO, RIPPLE THERAPEUTICS CORPORATION

Ripple Therapeutics

Toronto, Ontario, Canada

David Richards

CHIEF EXECUTIVE OFFICER, CLARAMETYX BIOSCIENCES

Clarametyx Biosciences, Inc.

Columbus, Ohio, United States

Spiro Rombotis, MBA, MPH

PRESIDENT & CEO, CYCLACEL PHARMACEUTICALS, INC

Cyclacel Pharmaceuticals, Inc.

Berkeley Heights, New Jersey, United States

Amanda Rose

PARTNER, FENWICK & WEST, LLP

Seattle, Washington, United States

Philip Ross

VICE CHAIRMAN, INVESTMENT BANKING, J.P. MORGAN

Market Outlook: Breaking More Records or Expecting a Releveling?

New York, New York, United States

Steve Rowles

PARTNER, MORRISON & FOERSTER, LLP

Market Outlook: Breaking More Records or Expecting a Releveling?

San Diego, California, United States

Susan Ruediger

CEO, CHARCOT-MARIE-TOOTH RESEARCH FOUNDATION

CMT Research Foundation

Atlanta, Georgia, United States

Stephen Russell, PHD, MD

PRESIDENT & CEO, VYRIAD, INC.

Vyriad, Inc.

Rochester, Minnesota, United States

Alif Saleh

CEO, SCIPHER MEDICINE

Scipher Medicine

Waltham, Massachusetts, United States

Gaston Salinas

CEO, BOTANICAL SOLUTION INC

Botanical Solution Inc (BSI)

Chula Vista, California, United States

Mark Sampson, MD

CEO, CIRCADIAN THERAPEUTICS

Circadian Therapeutics

Oxford, United Kingdom

James Sapirstein, MBA, RPH

CHIEF EXECUTIVE OFFICER, AZURRX BIOPHARMA INC.

AzurRx BioPharma

Delray Beach, Florida, United States

Christopher Schaber, PHD

PRESIDENT & CEO, SOLIGENIX, INC.

Soligenix, Inc.

Princeton, New Jersey, United States

Oscar Segurado, MD, PHD

CMO, ASC THERAPEUTICS, INC

ASC Therapeutics

Milpitas, California, United States

Kunwar Shailubhai

CEO/CSO, TIZIANA LIFE SCIENCES

Tiziana Life Sciences Plc

London, United Kingdom

Scott Shively

CHIEF EXECUTIVE OFFICER, NEUMENTUM, INC.

Neumentum, Inc.

Morristown, New Jersey, United States

Sanjay Shukla, MD, MS

PRESIDENT, CEO, ATYR PHARMA, INC.

aTyr Pharma, Inc.

San Diego, California, United States

Ali Siam

CHIEF BUSINESS OFFICER, CELMATIX, INC.

Celmatix

New York, New York, United States

Rahul Singhvi

CHIEF EXECUTIVE OFFICER, NATIONAL RESILIENCE INC.

Fireside Chat: Rahul Singhvi, SC.D., M.B.A, Chief Executive Officer and Director, National Resilience, Inc.

La Jolla, California, United States

Mark Sirgo, PHARMD

CHIEF EXECUTIVE OFFICER, ARUNA BIO

Aruna Bio

Athens, Georgia, United States

David Slack

PRESIDENT & CEO, CEND THERAPEUTICS INC.

Cend Therapeutics, Inc.

San Diego, California, United States

Yochi Slonim

CO-FOUNDER AND CEO, ANIMA BIOTECH INC.

Anima Biotech

Bernardsville, New Jersey, United States

Ipsita Smolinski, MBA

MANAGING DIRECTOR, CAPITOL STREET; FACULTY, HEALTHCARE FINANCE, JOHNS HOPKINS UNIVERSITY CAREY BUSINESS SCHOOL

Washington, ,DC, Virginia, United States

Mina Sooch

CEO, OCUPHIRE PHARMA INC

Ocuphire Pharma, Inc.

Farmington, Michigan, United States

Caroline Stark Beer

CHIEF BUSINESS OFFICER, JNANA THERAPEUTICS

Deal Making in a New Decade: Lessons Learned and Planning for Tomorrow

Cambridge, Massachusetts, United States

Lisa Stehno-Bittel, PHD

PRESIDENT & FOUNDER, LIKARDA, LLC

Likarda, LLC

Kansas City, Missouri, United States

Subree Subramanian, MS, PhD

CSO, EV THERAPEUTICS, INC.

EV Therapeutics, Inc.

Belmont, California, United States

Marco Taglietti, MD

PRESIDENT & CHIEF EXECUTIVE OFFICER, SCYNEXIS, INC.

SCYNEXIS, Inc.

Jersey City, New Jersey, United States

Charles Theuer, PHD, MD

PRESIDENT & CEO, TRACON PHARMACEUTICALS, INC

TRACON PHARMACEUTICALS, INC.

San Diego, California, United States

Marc Thibonnier, MD

FOUNDER & PRESIDENT, APTAMIR THERAPEUTICS, INC.

AptamiR Therapeutics, Inc.

Naples, Florida, United States

David Thomas

VICE PRESIDENT, INDUSTRY RESEARCH, BIOTECHNOLOGY INNOVATION ORGANIZATION

Washington, United States

George Tidmarsh, MD, PHD

CHAIRMAN, REVELATION BIOSCIENCES INC

Revelation Biosciences Inc

Menlo Park, California, United States

Pascal Touchon

PRESIDENT & CEO, ATARA BIOTHERAPEUTICS

Atara Biotherapeutics, Inc.

South San Francisco, California, United States

Agne Vaitkeviciene

PROJECT MANAGER, BALTYMAS, UAB

Baltymas, UAB

Vilnius, Lithuania

Dan Vickery

FOUNDER, IXALTIS USA

IXALTIS USA

Bound Brook, New Jersey, United States

Francois Vigneault, PHD

PRESIDENT AND CEO, SHAPE THERAPEUTICS, INC.

Seattle, Washington, United States

Stefan Weber

CEO, MANAGING DIRECTOR, NEWRON PHARMACEUTICALS SPA

NEWRON PHARMACEUTICALS SPA

BRESSO, Italy

Martin Welschof, PHD

CEO, BIOINVENT INTERNATIONAL AB

BioInvent International AB

Lund, Sweden

Russell Wilson

ACTING CHIEF EXECUTIVE OFFICER AND CHIEF SCIENTIFIC OFFICER, STADIUS BIOPHARMA LLC

Stadius Biopharma LLC

New Orleans, Louisiana, United States

Blake Wise

CHIEF EXECUTIVE OFFICER, NOVOME BIOTECHNOLOGIES, INC.

Novome Biotechnologies

South San Francisco, California, United States

Jeffrey Wolf

FOUNDER, CHAIRMAN AND CEO, HEAT BIOLOGICS, INC

Heat Biologics

Morrisville, North Carolina, United States

Adam Woodrow

PRESIDENT & CHIEF COMMERCIAL OFFICER, PARATEK PHARMACEUTICALS, INC

Paratek Pharmaceuticals

Boston, Massachusetts, United States

Guo-Liang Yu, PHD

CHIEF EXECUTIVE OFFICER, APOLLOMICS, INC.

Foster City, California, United States

James Zhao

FOUNDING PARTNER, LYFE CAPITAL